Program

In-person AND virtual! – We are pioneering a new conference format that will connect in-person and virtual audiences to create a unique experience. Matching the innovation that comes through our members’ work, ISPOR is pushing the boundaries of innovation to design an event that works in today’s quickly changing environment. 

In-person registration included the full virtual experience, and virtual-only attendees will be able to tune into live in-person sessions and/or watch captured in-person sessions on-demand in addition to having a variety of virtual-only sessions to attend.

How Can We Make the Study of Patient Preferences More Useful to Decision-Makers in Health? The Final Recommendations from the ISPOR Using Patient Preferences to Inform Decision Making Good Practices Task Force

Speaker(s)

Moderator: John F P Bridges, PhD, Department of Biomedical Informatics and Surgery, Ohio State University College of Medicine, Columbus, OH, USA
Speakers: Deborah Marshall, PhD, BSc, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Sebastian Heidenreich, MSc, PhD, Evidera, London, LON, UK; Laura Lee Johnson, PhD, CDER, Food and Drug Administration, Silver Spring, MD, USA

Presentation Documents

There is growing interest in increasing the use and relevance of patient preferences studies among decision makers in health. Our task force focused on developing a new framework that would: 1) be applicable to the wide variety of preference methods; 2) identify key domains that would guide researchers and other stakeholders in making patient preference studies more useful to decision makers; and 3) detail important questions that would guide researchers conducting preference studies and those critically appraising them.

The framework spans 5 domains for conducting patient preference studies to increase the use and relevance of these studies to decision makers: i. The context – A complete understanding of how decision makers function, how decisions are made, and how studies on patient preferences may be received and used. ii. The purpose – A clear articulation of how the study on patient preferences responds to decision makers’ needs and how the findings are expected to inform decision making. iii. The population – A thorough consideration of who the findings of the study will be applied to (directly or indirectly) and the intended and unintended consequences for those people. iv. The method – A selection of method/s to study patient preferences that reflects the needs, wants, and capabilities of decision makers, patients, and other stakeholders. v. The impact – A proactive effort both to ensure that the study findings can inform decision making and to measure if and how they influenced decision makers and decision-making.

Speakers will discuss: 1) a detailed overview of the ISPOR Framework; 2) compare it to different preference elicitation methods’ frameworks/recommendations such as IMI PREFER; 3) it’s application to a decision-relevant case study and 4) the decision-maker’s perspective. Feedback on bridging the gap between methods and applications will be part of the polling and moderated Q&A session.

Code

232